{"id":"https://openalex.org/W2322668642","doi":"https://doi.org/10.1097/fjc.0000000000000120","title":"Effects of Glucagon-like Peptide-1 in Diabetic Rat Small Resistance Arteries","display_name":"Effects of Glucagon-like Peptide-1 in Diabetic Rat Small Resistance Arteries","publication_year":2014,"publication_date":"2014-06-02","ids":{"openalex":"https://openalex.org/W2322668642","doi":"https://doi.org/10.1097/fjc.0000000000000120","mag":"2322668642","pmid":"https://pubmed.ncbi.nlm.nih.gov/24887687"},"language":"en","primary_location":{"id":"doi:10.1097/fjc.0000000000000120","doi":"https://doi.org/10.1097/fjc.0000000000000120","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fjc.0000000000000120","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112107418","display_name":"Zeliha Bayram","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I197907453","display_name":"Akdeniz University","ror":"https://ror.org/01m59r132","country_code":"TR","type":"education","lineage":["https://openalex.org/I197907453"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Zeliha Bayram","raw_affiliation_strings":["Department of Medical Pharmacology, Medical Faculty, Akdeniz University, Antalya, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology, Medical Faculty, Akdeniz University, Antalya, Turkey","institution_ids":["https://openalex.org/I197907453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026553460","display_name":"Cahit Nac\u0131tarhan","orcid":"https://orcid.org/0000-0003-2601-4921","observed_orcids":["https://orcid.org/0000-0003-2601-4921"]},"institutions":[{"id":"https://openalex.org/I197907453","display_name":"Akdeniz University","ror":"https://ror.org/01m59r132","country_code":"TR","type":"education","lineage":["https://openalex.org/I197907453"]}],"countries":["TR"],"is_corresponding":false,"raw_author_name":"Cahit Nacitarhan","raw_affiliation_strings":["Department of Medical Pharmacology, Medical Faculty, Akdeniz University, Antalya, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology, Medical Faculty, Akdeniz University, Antalya, Turkey","institution_ids":["https://openalex.org/I197907453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5069187186","display_name":"Sadi S. \u00d6zdem","orcid":"https://orcid.org/0000-0003-4325-5209","observed_orcids":["https://orcid.org/0000-0003-4325-5209"]},"institutions":[{"id":"https://openalex.org/I197907453","display_name":"Akdeniz University","ror":"https://ror.org/01m59r132","country_code":"TR","type":"education","lineage":["https://openalex.org/I197907453"]}],"countries":["TR"],"is_corresponding":true,"raw_author_name":"Sadi S. Ozdem","raw_affiliation_strings":["Department of Medical Pharmacology, Medical Faculty, Akdeniz University, Antalya, Turkey"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Pharmacology, Medical Faculty, Akdeniz University, Antalya, Turkey","institution_ids":["https://openalex.org/I197907453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5069187186"],"corresponding_institution_ids":["https://openalex.org/I197907453"],"apc_list":null,"apc_paid":null,"fwci":0.4358,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.64008528,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"64","issue":"3","first_page":"277","last_page":"284"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5121999979019165,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.5121999979019165,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10155","display_name":"Nitric Oxide and Endothelin Effects","score":0.3571999967098236,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10814","display_name":"Neuropeptides and Animal Physiology","score":0.053300000727176666,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/glucagon-like-peptide-1","display_name":"glucagon-like peptide-1","score":0.9950000047683716},{"id":"https://openalex.org/keywords/glp-1-7-36","display_name":"GLP-1(7-36)","score":0.9850000143051147},{"id":"https://openalex.org/keywords/diabetes-mellitus","display_name":"diabetes mellitus","score":0.8209999799728394},{"id":"https://openalex.org/keywords/small-resistance-arteries","display_name":"small resistance arteries","score":0.9480000138282776},{"id":"https://openalex.org/keywords/vasorelaxation","display_name":"vasorelaxation","score":0.8389999866485596},{"id":"https://openalex.org/keywords/endothelium-dependent-relaxation","display_name":"endothelium-dependent relaxation","score":0.7850000262260437},{"id":"https://openalex.org/keywords/nitric-oxide-cgmp-pathway","display_name":"nitric oxide-cGMP pathway","score":0.7789999842643738},{"id":"https://openalex.org/keywords/calcium-activated-potassium-channels","display_name":"calcium-activated potassium channels","score":0.8539999723434448},{"id":"https://openalex.org/keywords/reactive-oxygen-species","display_name":"reactive oxygen species","score":0.843999981880188},{"id":"https://openalex.org/keywords/superoxide-dismutase","display_name":"superoxide dismutase","score":0.9990000128746033},{"id":"https://openalex.org/keywords/exendin-9-39","display_name":"exendin-9-39","score":0.9129999876022339},{"id":"https://openalex.org/keywords/glp-1-receptor","display_name":"GLP-1 receptor","score":0.9100000262260437}],"concepts":[{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7436413764953613},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7077105641365051},{"id":"https://openalex.org/C2779768347","wikidata":"https://www.wikidata.org/wiki/Q420626","display_name":"Glibenclamide","level":3,"score":0.6109039783477783},{"id":"https://openalex.org/C2776919887","wikidata":"https://www.wikidata.org/wiki/Q417260","display_name":"Apamin","level":3,"score":0.6022240519523621},{"id":"https://openalex.org/C2775838275","wikidata":"https://www.wikidata.org/wiki/Q410776","display_name":"Superoxide dismutase","level":3,"score":0.5885963439941406},{"id":"https://openalex.org/C519581460","wikidata":"https://www.wikidata.org/wiki/Q207843","display_name":"Nitric oxide","level":2,"score":0.5031628012657166},{"id":"https://openalex.org/C2780994212","wikidata":"https://www.wikidata.org/wiki/Q422511","display_name":"Cyclic guanosine monophosphate","level":3,"score":0.49639636278152466},{"id":"https://openalex.org/C2776992346","wikidata":"https://www.wikidata.org/wiki/Q111140","display_name":"Endothelium","level":2,"score":0.4951242506504059},{"id":"https://openalex.org/C2776398474","wikidata":"https://www.wikidata.org/wiki/Q424611","display_name":"Glucagon-like peptide-1","level":4,"score":0.4425353407859802},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4191572666168213},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.35317566990852356},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.27294015884399414},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.267598956823349},{"id":"https://openalex.org/C83743174","wikidata":"https://www.wikidata.org/wiki/Q423778","display_name":"Potassium channel","level":2,"score":0.23950165510177612},{"id":"https://openalex.org/C2776151105","wikidata":"https://www.wikidata.org/wiki/Q898814","display_name":"Oxidative stress","level":2,"score":0.16150495409965515}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001030","descriptor_name":"Apamin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001158","descriptor_name":"Arteries","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001158","descriptor_name":"Arteries","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D003921","descriptor_name":"Diabetes Mellitus, Experimental","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D004730","descriptor_name":"Endothelium, Vascular","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D005905","descriptor_name":"Glyburide","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006152","descriptor_name":"Cyclic GMP","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009569","descriptor_name":"Nitric Oxide","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D010446","descriptor_name":"Peptide Fragments","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D010455","descriptor_name":"Peptides","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D013482","descriptor_name":"Superoxide Dismutase","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D015761","descriptor_name":"4-Aminopyridine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D017208","descriptor_name":"Rats, Wistar","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017382","descriptor_name":"Reactive Oxygen Species","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D018999","descriptor_name":"Charybdotoxin","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D024681","descriptor_name":"Potassium Channels, Calcium-Activated","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D052216","descriptor_name":"Glucagon-Like Peptide 1","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/fjc.0000000000000120","doi":"https://doi.org/10.1097/fjc.0000000000000120","is_oa":false,"landing_page_url":"https://doi.org/10.1097/fjc.0000000000000120","pdf_url":null,"source":{"id":"https://openalex.org/S61167191","display_name":"Journal of Cardiovascular Pharmacology","issn_l":"0160-2446","issn":["0160-2446","1533-4023"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Cardiovascular Pharmacology","raw_type":"journal-article"},{"id":"pmid:24887687","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/24887687","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of cardiovascular pharmacology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W1968939832","https://openalex.org/W1970445852","https://openalex.org/W1972038430","https://openalex.org/W1972757710","https://openalex.org/W1989640659","https://openalex.org/W1993285386","https://openalex.org/W2000465889","https://openalex.org/W2000976083","https://openalex.org/W2004891119","https://openalex.org/W2005140805","https://openalex.org/W2011601530","https://openalex.org/W2011683287","https://openalex.org/W2013529909","https://openalex.org/W2021213106","https://openalex.org/W2040354067","https://openalex.org/W2042845313","https://openalex.org/W2047467581","https://openalex.org/W2066647269","https://openalex.org/W2075024723","https://openalex.org/W2077372959","https://openalex.org/W2078128383","https://openalex.org/W2083023900","https://openalex.org/W2083783526","https://openalex.org/W2085341566","https://openalex.org/W2089736652","https://openalex.org/W2090146088","https://openalex.org/W2102641536","https://openalex.org/W2110576471","https://openalex.org/W2116478518","https://openalex.org/W2124633895","https://openalex.org/W2129730863","https://openalex.org/W2130083450","https://openalex.org/W2139470224","https://openalex.org/W2147226546","https://openalex.org/W2169976140","https://openalex.org/W2411384485"],"related_works":["https://openalex.org/W2005140805","https://openalex.org/W2899659933","https://openalex.org/W2989380208","https://openalex.org/W4393286795","https://openalex.org/W1977390245","https://openalex.org/W2982203714","https://openalex.org/W2041238443","https://openalex.org/W3094565916","https://openalex.org/W2208659366","https://openalex.org/W2124633895"],"abstract_inverted_index":{"We":[0,139],"investigated":[1],"the":[2,12,18,143],"functional":[3],"effects":[4,19,145],"of":[5,20,35,146,191],"glucagon-like":[6],"peptide-1":[7],"[GLP-1(7-36)]":[8],"and":[9,11,30,37,83,98,104,110,115,148,163,196],"GLP-1(9-36)":[10,38,80,149,197],"mechanism(s)":[13],"playing":[14],"a":[15,127,166,185],"role":[16,168,186],"in":[17,23,42,52,81,113,130,136,150,156,169,172,179,187,198],"these":[21],"agents":[22],"isolated":[24],"small":[25],"resistance":[26,151,192],"arteries":[27,47,152,193],"from":[28],"control":[29,82,114],"diabetic":[31,53,84,116,137,157,199],"rats.":[32,54,85,117,138,158,200],"Cumulative":[33],"concentrations":[34],"GLP-1(7-36)":[36,78,147,195],"produced":[39],"concentration-dependent":[40],"relaxations":[41,93,100,131],"endothelium-intact":[43],"but":[44,71],"not":[45,72,91,120],"endothelium-denuded":[46],"that":[48,153],"were":[49,101,154],"significantly":[50,59,74,103],"decreased":[51,75],"GLP-1":[55,63,95,133],"receptor":[56],"antagonist":[57],"exendin(9-39)":[58],"inhibited":[60],"responses":[61,76,190],"to":[62,77,94,105,132,194],"analogs.":[64,96],"Nitric":[65],"oxide/cyclic":[66],"guanosine":[67],"monophosphate":[68],"pathway":[69],"blockers,":[70],"indomethacin,":[73],"or":[79,87],"4-Aminopyridine":[86],"glibenclamide":[88],"incubation":[89],"did":[90,119],"alter":[92],"GLP-1(7-36)-":[97],"GLP-1(9-36)-induced":[99],"blunted":[102],"similar":[106],"extends":[107],"by":[108],"charybdotoxin":[109],"apamin":[111],"combination":[112],"Catalase":[118],"affect,":[121],"whereas":[122],"superoxide":[123,180],"dismutase":[124,181],"(SOD)":[125],"caused":[126],"significant":[128],"increase":[129],"analogs":[134],"only":[135],"provided":[140],"evidence":[141],"about":[142],"relaxant":[144,189],"reduced":[155,188],"Both":[159],"calcium-activated":[160],"potassium":[161],"channels":[162],"endothelium":[164],"played":[165],"major":[167],"relaxations.":[170],"Increment":[171],"certain":[173],"reactive":[174],"oxygen":[175],"species":[176],"and/or":[177],"reduction":[178],"function":[182],"might":[183],"play":[184]},"counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":3},{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-11T12:16:26.678958","created_date":"2016-06-24T00:00:00"}